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1332Objective: The long-term outcomes of combined mitral repair and maze procedure for patients with nonrheu-
matic mitral regurgitation and chronic atrial fibrillation were evaluated.
Methods: Between June 1992 and December 2008, 187 patients underwent a combined mitral repair and maze
procedure. The mean follow-up period was 7.4 4.3 years. Chordal reconstruction was performed in 69 patients,
leaflet resection in 91, edge-to-edge leaflet suture in 30, and ring annuloplasty in 156. In addition, a cryo-maze
procedure was applied in 110, and a Cox–Kosakai maze and radiofrequency maze were applied in the others.
Results: There were 2 operative deaths and the 15-year survival was 71%. The 15-year freedom from greater than
grade 3 mitral regurgitation was 61%; rates of freedom from heart failure (New York Heart Association class 
III) and reoperations were 79% and 91%, respectively. Cardiac function was improved and left ventricular size
was decreased significantly postoperatively. Multivariate analysis showed that a large left ventricular diastolic
diameter (65 mm) was an independent risk factor for recurrent mitral regurgitation. Eleven thromboembolic
episodes (0.79%/patient-year) were detected during follow-up examinations, of which 7 occurred in patients
with recurrent atrial fibrillation. Sinus rhythm was regained in 86% after 6 months and in 63% after 15 years.
Multivariate analysis showed that a small-voltage f wave was an independent risk factor for AF recurrence.
Conclusions: A combined mitral valve repair and maze procedure provided low rates of morbidity and mortality
and led to well-preserved cardiac function. Left ventricular diastolic diameter and f-wave voltage can be accurate
predictors of good long-term outcome. (J Thorac Cardiovasc Surg 2010;140:1332-7)A mitral valve repair operation has become standard for non-
rheumatic mitral valve regurgitation (MR), and recent reports
have shown satisfactory midterm to long-term results, includ-
ing freedom from reoperation and severeMR.1-3However, for
yet unexplained reasons, in some patients who undergo the
procedure the mitral valve does not remain competent.3 In
addition to the pathophysiology of MR, ring annuloplasty,
and preoperative heart failure status, persistent atrial fibrilla-
tion (AF) has been suggested to affect the long-term clinical
outcome and durability of mitral repair.3-7 On the other
hand, preoperative AF is reported to be a marker not only
for surgical risk, but also for late adverse cardiac events and
stroke; thus, sinus conversion is an important strategy for
patients with AF, who are estimated to comprise from 30%
to 40% of all patientswho need amitral operation.7 Therefore,
a maze procedure is as important as mitral repair to achieve
a good long-term outcome. Patients with persistent AF tend
to have a longer history of congestive heart failure and maye Department of Cardiovascular Surgery, National Cardiovascular Center,
, Japan.
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The Journal of Thoracic and Cardiovascular Surbenefit greatly from a combinedmitral repair andmaze proce-
dure.We analyzed long-termoutcomes of patientswho under-
went combination therapy consisting of mitral repair and
a maze procedure for nonrheumatic MR and persistent AF.METHODS
Patients and Assessment
One hundred eighty-seven consecutive patients (mean 62 11 years old,
70%male, mean body surface area 1.58 0.17 m2) who underwent a com-
bined mitral repair and maze procedure for MR owing to nonrheumatic eti-
ology and persistent AF from June 1992 to December 2008 were studied
retrospectively. One hundred one (54%) had New York Heart Association
(NYHA) class II congestive heart failure, 60 (32%) had NYHA class III,
and 26 (14%) had NYHA class IV symptoms.
MR was assessed by color-flow Doppler ultrasonography, with the seve-
rity graded as none (0), trivial (1), mild (2), moderate (3), or severe (4). All pa-
tients hadmoderate or severeMR, and its etiologywas anterior leaflet prolapse
in 53 (28%), posterior leaflet prolapse in 75 (40%), both leaflets in prolapse in
33 (18%), and annular dilatation in 27 (14%). All patients were in persistent
AF rhythm. The averageAFdurationwas 3.5 4.1 years and the durationwas
longer than 10 years in 15 (8%) patients. The height of the f wave in V1 of the
12-lead electrocardiogram was less than 0.1 mV in 25 (19%) patients. The
preoperative average left atrial (LA) diameter was 60  11 mm and greater
than70mmin15 (8%). In all patients, the preoperative average left ventricular
(LV) diastolic and systolic diameters were 63  4.6 mm and 36  8.5 mm,
respectively, the average fraction shorteningwas 35% 8%, and the average
peak tricuspid regurgitant pressure gradient was 35 14 mm Hg.
Procedures
Appropriate repair techniques were directed to specific structures of the
mitral valve (Table 1). Leaflet resection such as a quadrangular or triangulargery c December 2010
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AF ¼ atrial fibrillation
LA ¼ left atrial (atrium)
LV ¼ left ventricular (ventricle)
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Dresection was used in 91 (49%) patients, chordal reconstruction such as
replacement with artificial chordae8 or chordal transfer was used in 69
(37%), and edge-to-edge repair, applied only to commissure lesions, was
used in 30 (16%). A ring or band annuloplasty was performed in 156
(83%) patients. The ring annuloplasty was applied regularly in the later
years, although it was not applied to every patient for the first several years
in our series. A cryo-maze procedure was used in 110 patients (59%),9
a Cox or Kosakai maze in 69 (37%),10,11 and a radiofrequency maze in 8
(4.3%). The different types of maze procedures were selected by different
time eras, because the procedure became less invasive with time. The
cryo-maze procedure is the least invasive among the Cox, Kosakai, and
cryo-maze procedures and it is the current procedure. Radiofrequency
maze, which modified the energy source simply from liquid nitrogen to ra-
diofrequency, was discontinued because of the uncertain transmurality. The
Cox maze was performed with a cut-and-sew technique. The Kosakai mod-
ification switched cut-and-sew to cryoablation on the lines from the right
atrial free wall to the inferior vena cava, from the left upper pulmonary
vein to the LA appendage, and on the extension lines to the mitral and tri-
cuspid valves.11 It also ablated the line from the right atrial appendage to
the foramen ovale instead of the line of the intra-atrial septum to the foramen
ovale, and stopped to ablate the line to the superior vena cava.9 It also pre-
served biatrial appendages that were cut out in the original Cox procedure.
The cryo-maze procedure simplified this method further, and the only lines
to cut were the right atrial free wall and right side of the LA, which had to be
cut for tricuspid and mitral valve surgery. The cryoablation lines were the
lines to the inferior vena cava and tricuspid annulus, the intra-atrial septum
to foramen ovale in the right atrium, and box lines encircling bilateral pul-
monary veins and lines to the LA appendage and mitral annulus in the LA.
Radiofrequency maze was performed on the same lines as the cryo-maze
using a radiofrequency power source instead of liquid nitrogen.
Concomitantly, a tricuspid valve annuloplasty was performed in 70
(37%) patients, aortic valve surgery was performed in 15 (8.0%), coronary
artery bypass grafting was performed in 14 (7.5%), atrial septal defect clo-
sure was performed in 11 (5.9%), and LV restoration was performed in
3 (1.6%). LA reduction procedures were not performed.
Follow-up Examinations
All patients were contacted by telephone and during an outpatient clinic
visit for follow-up examinations. A standardized questionnaire was used
for symptomatic evaluations. Echocardiographic follow-up studies were
generally performed at the National Cardiovascular Center at 1, 3, 5, 10,
and 15 years after surgery, regardless of symptoms. Electrocardiograms
were routinely performed at the outpatient clinic every 6 to 12 months re-
gardless of symptoms and done immediately if a patient demonstrated any
symptoms. Complete follow-up information was available for 182 (97.5%)
patients because we lost contact with 5 during the follow-up period. The
mean length of follow-up for the survivors was 7.4  4.3 years, and
1400 hundred postoperative patient-years were available for analysis.
The durability of mitral repair was primarily assessed by performance of
a reoperation as well as by echocardiographic assessment. The durability
of the maze procedure was assessed by electrocardiographic findings; other
events briefly investigated included all-cause death, thromboembolism,
bleeding, and endocarditis.The Journal of Thoracic and CarPostoperative Management
All patients were treated with warfarin sodium (Coumadin) postopera-
tively and the target international normalized ratio was basically between
2.0 to 3.0, which was modified owing to the patient’s condition. Anticoagu-
lation was continued until 3 or 6 months’ time in the outpatient clinic, and it
was discontinued if the electrocardiogram showed sinus rhythm and the
patients did not feel palpitations. A Holter electrocardiographic study was
examined in case the patient had palpitations with sinus rhythm.
Cardioversion was tried only during the hospital stay, by intravenous
class Ia and/or class Ic antiarrhythmic agents with or without electrical car-
dioversion. An oral class Ia antiarrhythmic agent was continued for at most
several months, only when an intravenous agent was effective. Beta-blocker
was the basic strategy to maintain sinus rhythm, if applicable.
Data Analysis
Nonparametric, non–risk-adjusted estimates of freedom from events
were obtained by the method of Kaplan and Meier. A paired t test was
used to compare the degrees of LV diastolic and systolic diameters,
fractional shortening, and peak tricuspid regurgitant pressure gradient. A
univariate andmultivariate Cox hazard regression analysis was used to iden-
tify predictors of survival and freedom from events. All values are expressed
as the mean  standard deviation.
RESULTS
There were 2 (1.0%) operative deaths and 23 (12.3%)
late deaths. Seven of the late deaths were of cardiac origin
and included sudden death, and 2 were due to heart failure.
The 5-, 10-, and 15-year survivals for the entire series were
94%, 82%, and 71% (Figure 1, A).
There were 20 (10.7%) readmissions for heart failure
(NYHA class III), and the rates of freedom from heart fail-
ure after 5, 10, and 15 years were 93%, 86%, and 79%,
respectively (Figure 1, B). Eleven (5.9%) patients under-
went a reoperation, for recurrence of MR in 7, hemolysis
in 3, and endocarditis in 1. The rates of freedom from reop-
eration after 5, 10, and 15 years were 95%, 93%, and 91%,
respectively (Figure 1, C). Hemolysis was the main cause of
early failure of mitral repair; hemolysis resulting from partial
detachment of the annuloplasty ring occurred in 2 patients
and a regurgitant jet in 1. Echocardiographic follow-up
examinations revealed moderate or severe MR (3) in 25
(13%) patients during the follow-up period, and the rates
of freedom fromMR were 98%, 91%, 86%, and 61% after
1, 5, 10, and 15 years, respectively (Figure 1, D). Univariate
analysis showed that recurrence of MR of grade 3 or more
was associated with preoperative large LA diameter (70
mm) and LV diastolic diameter (65 mm), as well as recur-
rence of AF (Table 2). Multivariate Cox hazard regression
analysis revealed that a preoperative large value for LV di-
astolic diameter (65 mm) was the most significant risk fac-
tor for recurrence of MR of grade 3 or more. To determine
the impact of LV size on MR recurrence, we determined
the freedom rates in patients with a small LV (LV diastolic
diameter<65 mm, n ¼ 125) and large LV (LV diastolic di-
ameter 65 mm, n¼ 62) (Figure 1, E). The 10- and 15-year
rates of freedom from MR of grade 3 or more for the group
with a small LV were 91% and 69%, respectively, whereasdiovascular Surgery c Volume 140, Number 6 1333
TABLE 1. Baseline patient characteristics
Variables
Total patients, n (%) 187 (100%)
Male, n (%) 131 (70%)
Mean age, y (SD) 62 (11)
BSA, m2 (SD) 1.58 (0.17)
Hypertension, n (%) 46 (25)
Smoker, n (%) 37 (20)
Hyperlipidemia, n (%) 19 (10)
Diabetes mellitus, n (%) 16 (8.6)
NYHA class
II, n (%) 101 (54)
III, n (%) 60 (32)
IV, n (%) 26 (14)
Mitral leaflet prolapse
Anterior, n (%) 53 (28)
Posterior, n (%) 75 (40)
Both, n (%) 33 (18)
Nonprolapse etiology, n (%) 27 (14)
AF duration, y (SD) 3.5 (4.1)
AF duration>10 y, n (%) 15 (8.0)
f wave in V1<0.1 mV, n (%) 25 (19)
Echocardiographic measures
LA diameter, mm (SD) 60 (12)
LA diameter>70 mm, n (%) 15 (8.0)
LVDd, mm (SD) 63 (4.6)
LVDs, mm (SD) 36 (8.5)
Fraction shortening,% (SD) 35 (8.4)
TRPG, mm Hg (SD) 35 (14)
Procedures
Mitral repair
Leaflet resection, n (%) 91 (49)
Chordal reconstruction, n (%) 69 (37)
Edge to edge repair, n (%) 30 (16)
Ring (band) annuloplasty, n (%) 156 (83)
Maze procedure
Cryo-maze, n (%) 110 (59)
Cox/Kosakai maze, n (%) 69 (37)
Radiofrequency maze, n (%) 8 (4.3)
BSA, Body surface area; NYHA, New York Heart Association; AF, atrial fibrillation;
SD, standard deviation; LA, left atrial; LVDd, left ventricular diastolic diameter;
LVDs, left ventricular systolic diameter; TRPG, peak tricuspid regurgitant pressure
gradient.
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FIGURE 1. A, Actuarial survival after the operation. B, Rate of freedom
from NYHA class III heart failure or greater. C, Rate of freedom from reop-
eration. D, Rate of freedom from greater than moderate (3) MR. E, Rates
of freedom for small LV (line with white circle; LV diastolic diameter<65
mm, n¼ 125) and large LV (line with black circle; LV diastolic diameter
65 mm, n ¼ 62) groups. *P< .01.
Acquired Cardiovascular Disease Fujita et al
A
C
Dthose were 77% and 47%, respectively, for the group with
a large LV. Type of MR and site of prolapse were not signif-
icant factors for long-term durability of the mitral repair
(Table 2), nor was the type of repair, including lack of
ring annuloplasty.
Functional follow-up echocardiographic examination
showed that average LV diastolic diameter decreased from
63 to 49mm after 1 year and to 47mm after 15 years, changes
that were statistically significant (P< .01 vs preoperative
measurements) (Figure 2, A). The average LV systolic diam-
eter decreased from 36 to 30 mm after 1 year (not significant)
(Figure 2, A) and to 29 mm after 15 years (P< .05 vs pre-
operative measurements). The average fractional shortening1334 The Journal of Thoracic and Cardiovascular Surwas 35% preoperatively, then 34% after 1 year and 36% af-
ter 15 years (data not shown). Average peak tricuspid regur-
gitant pressure gradient also decreased from 35 to 25 mm Hggery c December 2010
TABLE 2. Predictors of recurrence of MR at grade greater than moderate (3): Univariate and multivariate analyses
Freedom from MR 3
Univariate Multivariate
Variables HR (95% CI) P value HR (95% CI) P value
NYHA (I, II) 0.48 (0.21–10.8) .0747 — —
Prolapse etiology 0.8 (0.27–2.34) .685 — —
Anterior prolapse 0.98 (0.45–2.15) .951 — —
Posterior prolapse 0.64 (0.29–1.41) .2667 — —
Both leaflets prolapse 0.64 (0.19–2.16) .4766 — —
Leaflet resection 0.54 (0.24–1.23) .1437 — —
Chordae reconstruction 1.29 (0.58–2.84) .5292 — —
Edge to edge repair 0.54 (0.13–2.28) .3979 — —
Ring annuloplasty 0.91 (0.31–1.84) .5408 — —
Recurrent AF rhythm 2.37 (1.09–5.33) .0368 2.16 (0.92–5.1) .0782
LV diastolic diameter  65 mm 2.86 (1.28–6.37) .0102 2.63 (1.12–6.17) .0268
LA diameter  70 mm 2.81 (1.05–7.5) .0394 2.12(0.42–3.815) .6847
MR, Mitral regurgitation; HR, hazard ratio; CI, confidence interval; NYHA, New York Heart Association; AF, atrial fibrillation; LV, left ventricular; LA, left atrial.
Fujita et al Acquired Cardiovascular Diseaseafter 1 year, which was a significant difference (P< .01)
(Figure 2, B), and was 26 mm Hg after 15 years.
Sinus rhythmwas regained in 86% patients after 6months
and was present in 79%, 70%, and 63% after 5, 10, and 15A
B
FIGURE 2. A, Left ventricular diastolic diameter (LVDd) and systolic di-
ameter (Ds) preoperatively and 1, 3, 5, 10, and 15 years after the operation.
*P< .05 versus preoperative LVDd. **P< .05 versus preoperative LVDs.
B, Peak tricuspid regurgitant pressure gradient (TRPG) preoperatively and
1, 3, 5, 10, and 15 years after the operation. *P< .05 versus preoperative
TRPG.
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Dyears, respectively (Figure 3, A). Univariate analysis showed
that a non–cryo-maze procedure, long AF history (10
years), small voltage of f wave in V1 ( 0.1 mV), and large
LA diameter (70 mm) were significant risk factors for AF
recurrence (Table 3). Multivariate Cox hazard regression
analysis revealed that a small f-wave voltage in V1 was the
most significant risk factor for AF recurrence. Eleven
(5.9%) thromboembolic episodes were detected in follow-
up examinations (0.79%/patient-year) and 7 occurred in
patients with recurrent AF rhythm (Figure 3, B).A
B
FIGURE 3. A, Rate of freedom from recurrence of atrial fibrillation (AF).
B, Rate of freedom from cerebral infarction.Open circle,Cerebral infarction
in patient with sinus rhythm. Closed circle, Cerebral infarction in patient
with recurrent AF.
diovascular Surgery c Volume 140, Number 6 1335
TABLE 3. Predictors of recurrence of AF: Univariate and multivariate analyses
Univariate Multivariate
Variables HR (95% CI) P value HR (95% CI) P value
Cryo-maze procedure 0.46 (0.25–0.86) .0153 0.91 (0.451–1.81) .7812
f wave in V1<0.1 mV 19.3 (10.1–36.9) <.0001 21.9 (10.0–47.9) <.0001
AF duration>10 y 4.47 (2.2–9.05) <.0001 1.56 (0.69–3.51) .2819
LA diameter  70 mm 4.14 (1.98–8.66) .0002 3.22 (1.42–7.27) .005
AF, Atrial fibrillation; HR, hazard ratio; CI, confidence interval; LAD, left atrial.
Acquired Cardiovascular Disease Fujita et al
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DDISCUSSION
In our previous report, we12 analyzed the efficacy of
a cryo-maze procedure for patients with AF who underwent
mitral valve surgery, which showed that sinus conversion is
likely to improve the rate of freedom from thromboembolic
events and restore enlarged LV size. Furthermore, LA size,
duration of AF, and f-wave voltage were found to be key
factors related to a successful maze procedure. In the present
study, we focused on long-term outcomes regarding acceler-
ated functional and survival benefits after a maze procedure
in addition to mitral repair. Although we applied 1-day Hol-
ter electrocardiographic monitoring only to patients with
a history of palpitations, recent expert consensus recom-
mends a 1- to 7-day Holter monitor study, a 4-week autotrig-
ger event monitor, or mobile cardiac outpatient telemetry to
identify asymptomatic recurrences of AF.13 Not only the
method of the maze procedure but also the follow-up strat-
egy should be adapted.
The success rate for the maze procedure was greater than
86% in our series of patients at 6 months’ follow-up and the
5-year rate of freedom from recurrent AF was 79%, which
are excellent rates when compared with other reports.14
The long-term results were also satisfactory, with 63% of
this high-risk patient group free from recurrent AF after
15 years. The LA diameter was significantly reduced from
an average 60 to 49 mm after the operation, although the
LA became enlarged over time for an average LA diameter
size of 55 mm after 15 years (data not shown). Re-expansion
of the LA diameter may contribute to recurrence of AF.
Risk factors for AF recurrence in the present study were
long AF history (10 years), small f-wave voltage in V1
(0.1 mV), and large LA diameter (70 mm), as previously
reported.15 Among those, a small f-wave voltage in V1 was
shown to be the most significant parameter, indicating that it
is the key factor to determine whether to perform amaze pro-
cedure. Avoidance of a cryo-maze procedure such as a Cox
or Kosakai procedure or ablation using an alternative energy
source was also found to be significant. Although it is un-
clear whether performance of a cryo-maze procedure pro-
vided a better outcome, we speculated that a cut-and-sew
technique might not reach the annulus adequately, and
a radiofrequency technique may not apply ablation deep
enough to the atrial wall. Therefore, combined with the cost
benefit, we think that a cryo-maze procedure is the best1336 The Journal of Thoracic and Cardiovascular Suroption. Furthermore, although the rate of freedom from cere-
bral infarction was satisfactory, 7 of 11 events occurred in pa-
tients with recurrent AF, emphasizing the importance of
a successful maze procedure to avoid cerebral infarction.
Concerning postoperative survival, we analyzed the
factors predictive of patient survival using a univariate
Cox hazard regression analysis. We found no significant
predictors for survival, such as preoperative NYHA class,
mitral lesions, reconstruction procedure, preoperative LV
or LA size, or postoperative sinus continuance. We specu-
lated that the sample size may be too small to obtain the sig-
nificant difference, because only 9 patients died of cardiac
events including sudden death (including hospital deaths)
among 187 patients.
As for valve and cardiac functions, the rates for survival
and long-term freedom from heart failure (NYHA class 
III) and reoperation were satisfactory, whereas our echocar-
diographic examinations found additional incidence of MR
recurrence. The mitral repair improved cardiac function
and accelerated reverse remodeling of the LV to downsize
it postoperatively, and those improvements were well main-
tained for a number of years. The rate of freedom from
recurrence of MR of grade 3 or more was excellent after
10 years, although it decreased to 61% after 15 years,
even though the number of patients at risk was small. Unex-
pectedly, univariate analysis showed that posterior leaflet
repair did not well suppress the recurrence rate of MR com-
pared with anterior repair, contrary to what was described in
other articles.3,16 This finding might be because of the earlier
establishment of artificial chordal reconstruction for anterior
repair in this study.8 However, further univariate and multi-
variate analyses revealed that a large LA and large LV are
primary contributors to MR recurrence and that AF recur-
rence was also associated with MR recurrence, indicating
common factors underlying recurrence of those conditions.
Among them, LV dilatation was shown to be an independent
risk factor for MR recurrence; thus, surgery before LV re-
modeling may be a key factor for long-term durability of
mitral repair. Reverse LV remodeling has been shown
to be associated with longer mitral repair durability in pa-
tients with advanced dilated cardiomyopathy or ischemic
cardiomyopathy accompanied by MR.17,18 Among patients
with cardiomyopathy in whom the LV is severely dilated,
some show echocardiographic evidence of reverse LVgery c December 2010
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a persistent or progressing remodeling pattern despite
a successful initial mitral repair.19-22 In combination with
these, reverse remodeling is a key factor for the long-term
durability of mitral repair, which may help reverse remodel-
ing in some cases, although in others it may not help down-
size the heart. Therefore, early indications of surgery before
remodeling of the LV can contribute to the long-term dura-
bility of mitral repair. Although valve replacement may be
considered instead of repair from the perspective of high
recurrence rate of MR in patients with a large LV, we still
recommend valve repair, which showed excellent rates of
long-term freedom from heart failure, reoperation, and cere-
bral infarction. Mitral repair in combination with a maze
procedure certainly confers good quality of life (Figure 1,
B and C, and Figure 3, B).
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